Latest news with #Active
Yahoo
8 hours ago
- General
- Yahoo
This bestselling $21 gel removes mould from grout, tubs and more — here's why shoppers love it
No matter how diligent you are about keeping your home clean, mould can happen in the most unlikely of places. From grout and caulking to washing machines and dishwashers, it's not uncommon for spots of mould to pop up wherever there's heat and moisture. Luckily, there are easy fixes that can help get rid of mould quickly, like the Active Seal & Grout Mould Stain Remover. The best part? It's currently on sale for $21 on Amazon Canada as part of their current deals on daily essentials. If you're looking for a way to get rid of mould and discolouration and save some money in the process, keep scrolling to learn more about this "magic" mould remover — and why more than 10,000 Amazon shoppers have purchased it in the past month. This easy-to-use mould remover has earned more than 5,000 reviews on Amazon. Active Seal & Grout Mould Stain Remover is an ammonia-free, Bisphenol A-free product that's used to remove unwanted spots from washing machine seals, dishwasher seals, tile, bathroom grout on the shower or tub, as well as door and window caulking. To use the product, apply it to a clean, dry surface and let it sit for approximately three to five hours. Remove it with a damp cloth or sponge, rinse with water and let the area air dry. ⭐️ 4/5 stars 💬 5,200+ reviews 🏆 "Wiped it off like magic." Active's Seal & Grout Mould Stain Remover has earned thousands of customer reviews from Amazon shoppers who say the product "works wonders" to remove the "black mould stains" that have "been around for years." "Absolutely loved this product," said one shopper who used it to remove mould under their sink. "Worked awesome." "I'm amazed at how well it worked in the washing machine," another said. Shoppers said that their bathroom smells "like a swimming pool" while the product is sitting, but "it works very well." Other shoppers said they used a majority of the bottle for one application, which is something to consider for bigger jobs. Others said that the product "helps a bit" but might need multiple applications for tougher jobs. If you're looking to tackle small jobs and remove mould or stains from grout around the house, Active's Seal & Grout Mould Stain Remover might be for you. The product has earned raved reviews from shoppers for removing mould around the bathroom and the washing machine. While the product is ammonia-free, people have said that it has a smell once it's applied, and it takes several hours to see results. Others have noted it may take a few applications for stubborn jobs, but people have said that it "works wonders" on mould that's been around for years.
Channel Post MEA
6 days ago
- Business
- Channel Post MEA
Synology Unveils Enterprise-Driven Innovations at Computex 2025
Joanne Weng, Director of International Business at Synology, shared that at Computex 2025, the company showcased its four core solution areas—file serving, backup, surveillance, and productivity—highlighting innovations to deepen its presence in the enterprise market. In storage, Synology introduced the PAS7700, an active-active NVMe all-flash storage solution designed for enterprise, mission-critical workloads. The company also unveiled its Grid Station, a scalable storage platform built to meet the evolving needs of corporate data environments. In the backup category, Synology launched Active Protect, a dedicated backup appliance reinforcing its commitment to robust data protection. On the surveillance front, the brand expanded its portfolio with AI-powered rack-mounted NVRs, PoE switches, and AI-integrated cameras, aligning with the growing demand for smart security systems. To boost workplace productivity, Synology enhanced its mail, chat, and office applications by integrating AI-driven features. Internally, the company also leveraged AI to streamline workflows and drive innovation across its operations. Addressing security and privacy concerns, Synology emphasized its proactive approach through its CERT team, which collaborates with white-hat hackers to identify and fix vulnerabilities. The company also continued its efforts to educate users on best practices for data protection and backup. By aligning with key trends such as AI adoption and scalable infrastructure, Synology underscored its commitment to innovation and enterprise readiness. Its continued participation in Computex reflects its drive to connect with a global audience and showcase its evolving capabilities. Looking ahead, Synology seeks to cement its position as a comprehensive, one-stop vendor offering end-to-end solutions and strong after-sales support for enterprise clients. 0 0
Forbes
25-05-2025
- Business
- Forbes
With Federal Legalization Stalled, Cannabis Companies Are Finding A New Green Rush In Europe
Alex Kwon, the cofounder and CEO of California-based vaporizer hardware manufacturer Active, started selling his THC oil vape tech to cannabis companies in the United Kingdom about two years ago. 'We started with putting our toe into the European market, but now we have a swimsuit on and we're walking in up to our belly,' says the 40-year-old Kwon, who cofounded the company in 2018. 'Soon we will be diving in.' Active, which Forbes estimates to generate more than $100 million in annual revenue, sells vaporizers made for oil to some of the biggest cannabis companies in the U.S., including Trulieve, Green Thumb Industries and Curaleaf. A few years ago, it did not have any business in Europe. Today, more than 5% of the company's revenue is derived from cannabis companies in the UK, which legalized medical marijuana in 2018, and Germany, which legalized medical use in 2017 and opened a limited recreational market in 2024. Kwon is currently negotiating a deal with an EU brand that would expand Active's European business even further. 'Europe could easily grow to 20% of our sales,' he says. Active's expansion outside America is one Kwon is not taking lightly. The EU, where about 25 countries have some form of cannabis legalization or decriminalization, is poised to become a $50 billion (annual sales) market if reform spreads across the entire continent, according to Whitney Economics. And Kwon wants Active to be on the ground floor of this new burgeoning cannabis industry. 'I think Europe is the battleground where cannabis is going to be won—it's the gateway to the rest of the world,' says Kwon. The U.S. cannabis market is projected to grow from $32 billion in annual sales to about $46 billion in three years, a 44% growth rate, according to data firm BDSA. But the EU is expected to grow 115% over the same period. And while cannabis companies in the U.S. cannot transport product across state lines, EU business can grow the crop in one country and export products around the continent. For now, the EU cannabis market is small. Annual sales this year are expected to reach $1.2 billion, according to a forthcoming report by Prohibition Partners. It is projected to reach $2.6 billion in 2028 and $6 billion in annual sales within a decade, or more than a 400% jump from this year. Germany, which is the EU's largest economy and the continent's largest legal marijuana industry with about $500 million in sales last year, is expected to generate just under $1 billion in sales at the end of 2025. The UK, which has not been part of the EU since Brexit in 2020, currently has a medical market with about $255 million in annual sales. The Netherlands and Switzerland both launched pilot programs to test recreational marijuana while Poland, Czech Republic, and other countries have launched medical programs. Malta and Luxembourg currently have adult-use programs and France has proposed medical legalization measures as well. Compared to the U.S., where 38 states have some form of legalization that generated $32 billion in annual legal cannabis sales last year, Europe's cannabis market is about the size of New Jersey's marijuana economy, but the potential upside and practical regulations that allow cannabis to be grown in Spain and Portugal and exported to other countries legally, has created a solid investment thesis for some U.S. companies to invest hundreds of millions of dollars in the EU. Beau Whitney, the founder of cannabis data firm Whitney Economics, says that Europe is an emerging market that's too important to ignore. While the U.S. has had a huge head start—California first legalized medical marijuana in 1996—the European market features government collaboration and financial incentives that the United States does not. (The barriers to entry in Europe are high, companies need to have EU GMP-certified facilities, but that's a good thing for investors because it lowers potential competition. Some countries only allow pharmaceutical cannabis products.) In the U.S., only 27% of cannabis companies are profitable, weighed down by federal prohibition, over regulation and punitive taxes on the state and local level. While former President Joe Biden launched a federal review to reclassify marijuana as a less dangerous drug—it is currently in the same category as heroin and LSD—the U.S. Drug Enforcement Administration has held up the review. And now with President Donald Trump in the White House, reform has come to a halt, despite the fact that he endorsed changes to the country's marijuana laws while on the campaign trail. 'The U.S. market is state by state and dysfunctional,' says Whitney. 'From an investment perspective, it's high risk, low return, which is upside down.' In contrast, countries like Germany have taken practical approaches to legalization and folded it into its existing medical establishment. In the UK and Germany, patients go to their regular doctor to get prescriptions for marijuana, which can be filled at traditional pharmacies or through online pharmacies that will deliver cannabis to a patient's house through the mail. Massachusetts-based Curaleaf is the largest U.S. player in Europe right now. The company expanded to the UK and the EU in 2021 when it acquired Emmac Life Sciences, a vertically integrated medical marijuana business with cultivation sites, manufacturing and distribution facilities across Germany, Italy, Portugal, Spain, and the UK for $286 million—$50 million in cash and 17.5 million shares of Curaleaf. Boris Jordan, the founder and CEO of Curaleaf, said during an earnings call after the Emmac acquisition that the European market 'will eventually rival the U.S.' Emmac has since been folded into Curaleaf's overseas strategy, becoming Curaleaf International. And when looking at revenue growth, Curaleaf's international growth dwarfs its U.S. operation. Last year, Curaleaf International generated $105 million in revenue, a 72% jump from 2023 when it made $61 million. In the U.S. meanwhile, Curaleaf generated $1.2 billion in 2024, or 1,000% more than its European division, but last year's stateside revenue is down slightly from $1.3 billion in 2023. Juan Pablo Martinez, CEO of Curaleaf International, believes that Jordan's prediction is quickly becoming a reality. 'The total addressable market is certainly there, the growth rates are certainly there, and I am confident that the market is going to be larger,' says Martinez. Meanwhile, Cookies, the cult weed brand cofounded by musician and entrepreneur Berner, sells cannabis in the UK, Germany, Israel, and Thailand and is about to launch sales in Australia. Working off a licensing model, Cookies has deals with three companies that grow its strains in Portugal, Germany and Canada. Parker Berling, the president of Cookies, says at first, expanding internationally was part of its strategy to be the first American brand in every country where pot is legal. Now, 'the international sector is the fastest growing part of our company,' says Berling. 'We've been selling internationally for years, but in the last few months and through the end of this year we're seeing it become a material part of our business.' Will Muecke, the cofounder of London-based marijuana-focused private equity firm Artemis Growth Partners, which has nearly $400 million in assets under management, is doubling down on Europe. Muecke says that Artemis, which has invested $200 million into U.S. cannabis companies since 2018, is no longer actively looking to invest in the North American market. Artemis has invested about $25 million in European companies since 2022, including Denmark-based Valcon, a cannabis extraction business, and Muecke says he sees an opportunity to invest up to $50 million more into the EU. 'Our [European strategy] is tail of the dog right now, but it's wagging the dog,' he says. 'It's crushing it.' Of course, not everyone is bullish on Europe. Kristoffer Inton, an analyst from Morningstar who covers cannabis companies, says the flood of interest from U.S. companies and especially Canadian companies, which are legally allowed to export marijuana to the EU, is not sustainable. 'The prospects of international medical marijuana are promising but it's also where everyone who is struggling sees it as a Godsend,' says Inton. 'If everyone sees it as a Godsend, it's probably going to not be a Godsend for anyone.' After all, the industry has heard a similar promise before. When Canada federally legalized cannabis in 2019, investors flooded the market with capital on the thesis that Canada could supply its home market, the U.S., and the globe. While reform has ground to a halt in the U.S., Canadian operators were caught with a glut of supply, the price per kilo of cannabis crashed and companies have been struggling to survive ever since. The same thing could happen in Europe, but with 745 million people, it would take a hell of a lot of weed to crash the market.
Cision Canada
23-05-2025
- Business
- Cision Canada
iA Clarington Investments announces May 2025 distributions for Active ETF Series Français
TORONTO, May 23, 2025 /CNW/ - IA Clarington Investments Inc. ("iA Clarington") today announced the May 2025 distributions for its Active ETF Series. Unitholders of record as of May 30, 2025 will receive cash distributions payable on June 10, 2025. Per-unit distributions are detailed below: For more information about IA Clarington Active ETF Series, please visit About IA Clarington Investments Inc. A subsidiary of Industrial Alliance Insurance and Financial Services Inc. – Canada's fourth-largest life and health insurance company – iA Clarington offers a wide range of investment products, including actively managed mutual funds, managed portfolio solutions, Active ETF Series and socially responsible investments. As of April 30, 2025, iA Clarington has over $21 billion in assets under management. For more information, please visit Commissions, trailing commissions, management fees, brokerage fees and expenses all may be associated with mutual fund investments, including investments in exchange-traded series of mutual funds. The information presented herein may not encompass all risks associated with mutual funds. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. The iA Clarington Funds are managed by IA Clarington Investments Inc. iA Clarington and the iA Clarington logo, iA Wealth and the iA Wealth logo, and iA Global Asset Management and the iA Global Asset Management logo are trademarks of Industrial Alliance Insurance and Financial Services Inc. and are used under license. iA Global Asset Management Inc. (iAGAM) is a subsidiary of Industrial Alliance Investment Management Inc. (iAIM). The payment of distributions and distribution breakdown, if applicable, is not guaranteed and may fluctuate. The payment of distributions should not be confused with a Fund's performance, rate of return, or yield. Distributions paid as a result of capital gains realized by a Fund and income and dividends earned by a Fund are taxable in the year they are paid. SOURCE IA Clarington Investments Inc.
India Today
20-05-2025
- Automotive
- India Today
Honda to celebrate 50 million global sales milestone with new two-wheeler reveal
Honda is all set to celebrate a global milestone tomorrow, and it is taking the opportunity to reveal a brand new two-wheeler. The two-wheeler in question will be a global model and will also be launched in India. This is what makes this reveal all the more sensational.'It started with one ride. Years of grit. Miles of trust. Driven by millions worldwide and counting. Spanning across continents and time. Stay tuned,' the teaser read. The announcement comes on the heels of a record-breaking fiscal year 2025, where Honda sold 20.57 million motorcycles, securing approximately 40% of the global market and achieving an all-time sales record across 37 countries and global motorcycle demand projected to grow from 50 million to 60 million units by 2030, driven by rising populations and incomes in the Global South, particularly India, Honda is poised to capture this surge through innovative products and an optimised supply chain. The company is accelerating its electrification efforts to maintain its environmental leadership, while also enhancing the fuel efficiency of its internal combustion engine (ICE) models and expanding flex-fuel options. In February 2025, Honda launched the Active e: and QC1 electric models in India, followed by the CUV e: and ICON e: in Indonesia, Vietnam, Thailand, and the Philippines, with the CUV e: slated for Europe and Japan later this support its electric ambitions, Honda plans to open a dedicated electric motorcycle production plant in India by 2028, leveraging modular designs to deliver affordable models and aiming to claim the top spot in the global electric motorcycle company's long-term vision targets a 50% global market share and a return on sales (ROS) exceeding 15% by fiscal year 2031 (ending March 31, 2031), driven by a robust lineup of both ICE and electric to Auto Today Magazine
